Trial NCT02381548

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2015-00257
Secondary IDs: 9853 MCC-12-07328 N01CM00100 NCI-2015-00257 NCI-9853 UM1CA186644 UM1CA186716

Last trial update was posted on 2018-05-25

MeSH Interventions

Adavosertib Belinostat

MeSH Conditions

Blast Crisis Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Recurrence Syndrome

Other Conditions

Acute Myeloid Leukemia Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Acute Myeloid Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID